首页> 外国专利> Cloning of human choline ethanolaminephospho transferases synthesis of phosphatidyl choline phosphatidyle thanolamine and platelet activating factor

Cloning of human choline ethanolaminephospho transferases synthesis of phosphatidyl choline phosphatidyle thanolamine and platelet activating factor

机译:人胆碱乙醇胺磷酸转移酶的克隆磷脂酰胆碱磷脂酰三醇胺的合成及血小板活化因子

摘要

We report the first cloning and expression, from a mammalian source, of proteins capable of catalyzing choline- and ethanolaminephosphotransferase reactions (hCEPT1 and hCEPT2). Both coding regions predict highly hydrophobic proteins of 43-46.5 kDa with several predicted membrane spanning domains. A CDP-alcohol phosphotransferase motif, DG(x)2AR(x)8G(x)3D(x)3D, has been identified in both hCEPT1 and hCEPT2 choline- and ethanolamine-phosphotransferases (and several other lipid synthesizing enzymes that catalyze the formation of a phosphoester bond by the displacement of CMP from a CDP-alcohol by a second alcohol). Site-directed mutagenesis was used to differentiate the residues responsible for choline- versus ethanolamine-phosphotransferase activity. Mutation of glycine 156 of hCEPT1 abolished ethanolaminephosphotransferase activity, while cholinephosphotransferase activity remained intact.
机译:我们报告第一个克隆和表达,从哺乳动物的来源,能够催化胆碱和乙醇胺磷酸转移酶反应(hCEPT1和hCEPT2)的蛋白质。两个编码区均预测具有43-46.5 kDa的高度疏水性蛋白,并具有几个预测的跨膜结构域。 CDP醇磷酸转移酶基序DG(x)2AR(x)8G(x)3D(x)3D已在hCEPT1和hCEPT2胆碱和乙醇胺磷酸转移酶(以及其他几种催化形成脂质的合成酶)中鉴定通过用第二种醇将CMP从CDP醇中取代而产生的磷酸酯键)。使用定点诱变来区分负责胆碱和乙醇胺磷酸转移酶活性的残基。 hCEPT1的甘氨酸156突变消除了乙醇胺磷酸转移酶的活性,而胆碱磷酸转移酶的活性保持不变。

著录项

  • 公开/公告号US6451568B1

    专利类型

  • 公开/公告日2002-09-17

    原文格式PDF

  • 申请/专利权人 DALHOUSIE UNIVERSITY;

    申请/专利号US20000719083

  • 发明设计人 CHRISTOPHER MCMASTER;ANETTE HENNEBERRY;

    申请日2000-12-08

  • 分类号C12P76/40;C12N91/20;C12N50/20;C07H210/40;

  • 国家 US

  • 入库时间 2022-08-22 00:48:55

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号